What Do Patients and Carers Need in Health Apps - but Are Not Getting?

Despite the huge and obvious potential of health apps to support patient self-care and reduce the drain on healthcare systems - their use has yet to move into mainstream medicine and public health programmes aimed at disease prevention. The lack of user involvement is one of the major reasons why health apps have failed to deliver thus far: what do patients and carers need in health apps - but are not getting? And how can developers respond and deliver better apps accordingly? These are the two key questions tackled in the latest analysis of the findings of a global survey and multi-stakeholder workshop, published by PatientView, in conjunction with Health 2.0 and TICBioMed, co-ordinator of the EU-funded GET project.

The results, presented in a new white paper, What do patients and carers need in health apps - but are not getting?, analyse the views of 1,130 patient and carer groups worldwide. The needs and challenges raised were then discussed in a multi-stakeholder meeting held to help define concepts for new apps that address patient and carer unmet real needs.

Download from eHealthNews.eu: What Do Patients and Carers Need in Health Apps - but Are Not Getting? (.pdf, 4.849 KB).

About PatientView
A UK-based research, publishing and consultancy group, PatientView has been collecting and analysing the perspectives of thousands of patients on their healthcare since 2000. It now has the capacity to reach out to 120,000 patient organisations worldwide, covering over 1,000 specialities. PatientView launched the myhealthapps.net website in November 2013 to provide an independent portal for patients, carers and health-conscious consumers to find apps that have been tried, tested and trusted by patient and health consumer groups.

About TICBioMed
TICBioMed is a cooperative cluster of companies, universities, healthcare providers and public institutions that work together to foster technological innovation in healthcare (eHealth). The association participates in the European projects GET, READi for Health and FICHe, and is the organiser of the EU SME eHealth Competition.

About Health 2.0
Since 2007 Health 2.0 Conferences have been the leading showcase of the cutting-edge technologies transforming health and healthcare. Health 2.0 promotes, showcases and catalyses new technologies in healthcare. We do this through a worldwide series of conferences, code-a-thons, prize challenges, and more. We also have the leading market intelligence on new health technology companies. Health 2.0 is a partner of the European project GET.

About the GET project
The European project GET delivers services to eHealth SMEs and entrepreneurs in order to boost their growth and move them to the next level of competitiveness. One of the delivered services is the systematic identification of ´unmet needs´ in Health. The objective is to support digital entrepreneurs to spot opportunities following a demand-driven approach (from the need to the solution) avoiding the technology push. The project also provides support regarding business modelling, internationalisation and private funding. This project has received funding from the European Union’s 7th Framework Programme for Research, technological development and demonstration under grant agreement no 611709.

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...